首页> 外文OA文献 >SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer

【2h】

SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer

机译：SOX30是一种预后的卵巢癌的预后生物标志物和化学治疗指示剂

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Fei Han; Wen-bin Liu; Jian-jun Li; Ming-qian Zhang; Jun-tang Yang; Xi Zhang; Xiang-lin Hao; Li Yin; Cheng-yi Mao; Xiao Jiang; Jia Cao; Jin-yi Liu;
展开▼
作者单位

展开▼
年度 2019
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer (vol 26, pg 303, 2019) [J] . Han Fei, Liu Wen-bin, Li Jian-jun, Mathematical research letters: MRL . 2020,第2期

机译：SOX30是一种预后的生物标志物和用于高级卵巢癌的化学治疗指标（Vol 26，PG 303,2019）
2. Independent prognostic significance of cell cycle regulator proteins p16INK4a and pRb in advanced-stage ovarian carcinoma including optimally debulked patients: a translational research subprotocol of a randomised study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group [J] . S Kommoss, A du Bois, R Ridder, British Journal of Cancer . 2007,第2期

机译：细胞周期调节蛋白p16INK4a和pRb在晚期卵巢癌（包括最佳减员）中的独立预后意义：Arbeitsgemeinschaft Gynaekologische Onkologie卵巢癌研究小组随机研究的翻译研究子协议
3. Prognostic factors for and prognostic value of mesenteric lymph node involvement in advanced-stage ovarian cancer [J] . GouyS., GoetgheluckJ., UzanC., European Journal of Surgical Oncology: The Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology . 2012,第2期

机译：肠系膜淋巴结受累与晚期卵巢癌的预后因素和预后价值
4. Application of statistical machine learning in identifying candidate biomarkers of resistant to anti-cancer drugs in ovarian cancer [C] . Nabavi Sheida, Maitituoheti Mayinuer, Yamada Michiyo, 2014 40th Annual Northeast Bioengineering Conference . 2014

机译：统计机器学习在确定卵巢癌抗癌药物耐药性候选生物标志物中的应用
5. Development of novel biomarkers in cancer: Detection of circulating miR-141 as a potential prognostic marker for prostate cancer. [D] . Gonzales, Jason Cadaoas. 2010

机译：癌症中新型生物标志物的开发：检测循环miR-141作为前列腺癌的潜在预后标志物。
6. Increased Expression of Holliday Junction-Recognizing Protein (HJURP) as an Independent Prognostic Biomarker in Advanced-Stage Serous Ovarian Carcinoma [O] . Lin Li, Xiaoli Li, Qin Meng, 1923

机译：霍利迪结识别蛋白（HJURP）的表达增加作为晚期浆液性卵巢癌的独立预后生物标志物。
7. Pretreatment lymphocytopenia is an adverse prognostic biomarker in advanced-stage ovarian cancer [O] . Yong Jae Lee, Young Shin Chung, Jung-Yun Lee, 2019

机译：预处理淋巴细胞病是晚期卵巢癌中的不良预后生物标志物

SOX30 is a prognostic biomarker and chemotherapeutic indicator for advanced-stage ovarian cancer

著录项

引文网络

相似文献

相关主题

期刊订阅